Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of levels of inequality of access to hormone replacement therapy and menopause care by (a) deprivation, (b) ethnicity and (c) geography.

We know that more needs to be done to address the barriers to accessing menopause care experienced by women, and that some groups of women experience these even more acutely. The Government is committed to prioritising women’s health as we reform the National Health Service, and women’s equality will be at the heart of our missions, our 10-Year Health Plan, and the renewal of the Women’s Health Strategy.

In October 2024, the NHS published a healthcare inequalities report into NHS primary care hormone replacement therapy prescribing to treat menopause symptoms. This report provides insights by age, deprivation, region, integrated care system (ICS), primary care network, local authority, electoral ward, and Core20, as well as specific medication level analysts. ICS’s and local authorities should use this information to inform policies, planning, commissioning, and promotion of services.

From 2026 onwards, local authorities will be asked to include menopause in the NHS Health Check which will support up to five million eligible women across England to access high quality information on the menopause, including advice on managing symptoms and where to seek support when they need it the most. To improve access and engagement with the NHS Health Check, a new NHS Health Check Online service is in development, which people can use at home, at a time convenient to them. The new online service is now being piloted in multiple local authorities.